PSMA PET/CT based multimodal deep learning model for accurate prediction of pelvic lymph-node metastases in prostate cancer patients identified as candidates for extended pelvic lymph node dissection by preoperative nomograms
IF 8.6 1区 医学Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Qiaoke Ma, Bei Chen, Robert Seifert, Rui Zhou, Ling Xiao, Jinhui Yang, Axel Rominger, Kuangyu Shi, Weikai Li, Yongxiang Tang, Shuo Hu
{"title":"PSMA PET/CT based multimodal deep learning model for accurate prediction of pelvic lymph-node metastases in prostate cancer patients identified as candidates for extended pelvic lymph node dissection by preoperative nomograms","authors":"Qiaoke Ma, Bei Chen, Robert Seifert, Rui Zhou, Ling Xiao, Jinhui Yang, Axel Rominger, Kuangyu Shi, Weikai Li, Yongxiang Tang, Shuo Hu","doi":"10.1007/s00259-024-07065-2","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>To develop and validate a prostate-specific membrane antigen (PSMA) PET/CT based multimodal deep learning model for predicting pathological lymph node invasion (LNI) in prostate cancer (PCa) patients identified as candidates for extended pelvic lymph node dissection (ePLND) by preoperative nomograms.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>[<sup>68</sup>Ga]Ga-PSMA-617 PET/CT scan of 116 eligible PCa patients (82 in the training cohort and 34 in the test cohort) who underwent radical prostatectomy with ePLND were analyzed in our study. The Med3D deep learning network was utilized to extract discriminative features from the entire prostate volume of interest on the PET/CT images. Subsequently, a multimodal model i.e., Multi kernel Support Vector Machine was constructed to combine the PET/CT deep learning features, quantitative PET and clinical parameters. The performance of the multimodal models was assessed using final histopathology as the reference standard, with evaluation metrics including area under the receiver operating characteristic curve (AUC), calibration curve, decision curve analysis, and compared with available nomograms and PET/CT visual evaluation result.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Our multimodal model incorporated clinical information, maximum standardized uptake value (SUV<sub>max</sub>), and PET/CT deep learning features. The AUC for predicting LNI was 0.89 (95% confidence interval [CI] 0.81–0.97) for the final model. The proposed model demonstrated superior predictive accuracy in the test cohort compared to PET/CT visual evaluation result, the Memorial Sloan Kettering Cancer Center (MSKCC) and the Briganti-2017 nomograms (AUC 0.85 [95% CI 0.69-1.00] vs. 0.80 [95% CI 0.64–0.95] vs. 0.79 [95% CI 0.61–0.97] and 0.69 [95% CI 0.50–0.88], respectively). The proposed model showed similar calibration and higher net benefit as compared to the traditional nomograms.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Our multimodal deep learning model, which incorporates preoperative PSMA PET/CT imaging, shows enhanced predictive capabilities for LNI in clinically localized PCa compared to PSMA PET/CT visual evaluation result and existing nomograms like the MSKCC and Briganti-2017 nomograms. This model has the potential to reduce unnecessary ePLND procedures while minimizing the risk of missing cases of LNI.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":"42 1","pages":""},"PeriodicalIF":8.6000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Nuclear Medicine and Molecular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00259-024-07065-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
To develop and validate a prostate-specific membrane antigen (PSMA) PET/CT based multimodal deep learning model for predicting pathological lymph node invasion (LNI) in prostate cancer (PCa) patients identified as candidates for extended pelvic lymph node dissection (ePLND) by preoperative nomograms.
Methods
[68Ga]Ga-PSMA-617 PET/CT scan of 116 eligible PCa patients (82 in the training cohort and 34 in the test cohort) who underwent radical prostatectomy with ePLND were analyzed in our study. The Med3D deep learning network was utilized to extract discriminative features from the entire prostate volume of interest on the PET/CT images. Subsequently, a multimodal model i.e., Multi kernel Support Vector Machine was constructed to combine the PET/CT deep learning features, quantitative PET and clinical parameters. The performance of the multimodal models was assessed using final histopathology as the reference standard, with evaluation metrics including area under the receiver operating characteristic curve (AUC), calibration curve, decision curve analysis, and compared with available nomograms and PET/CT visual evaluation result.
Results
Our multimodal model incorporated clinical information, maximum standardized uptake value (SUVmax), and PET/CT deep learning features. The AUC for predicting LNI was 0.89 (95% confidence interval [CI] 0.81–0.97) for the final model. The proposed model demonstrated superior predictive accuracy in the test cohort compared to PET/CT visual evaluation result, the Memorial Sloan Kettering Cancer Center (MSKCC) and the Briganti-2017 nomograms (AUC 0.85 [95% CI 0.69-1.00] vs. 0.80 [95% CI 0.64–0.95] vs. 0.79 [95% CI 0.61–0.97] and 0.69 [95% CI 0.50–0.88], respectively). The proposed model showed similar calibration and higher net benefit as compared to the traditional nomograms.
Conclusion
Our multimodal deep learning model, which incorporates preoperative PSMA PET/CT imaging, shows enhanced predictive capabilities for LNI in clinically localized PCa compared to PSMA PET/CT visual evaluation result and existing nomograms like the MSKCC and Briganti-2017 nomograms. This model has the potential to reduce unnecessary ePLND procedures while minimizing the risk of missing cases of LNI.
期刊介绍:
The European Journal of Nuclear Medicine and Molecular Imaging serves as a platform for the exchange of clinical and scientific information within nuclear medicine and related professions. It welcomes international submissions from professionals involved in the functional, metabolic, and molecular investigation of diseases. The journal's coverage spans physics, dosimetry, radiation biology, radiochemistry, and pharmacy, providing high-quality peer review by experts in the field. Known for highly cited and downloaded articles, it ensures global visibility for research work and is part of the EJNMMI journal family.